Date: 15 & 16 November 2025
Venue: Hilton Kuala Lumpur
This two-day scientific programme is designed for healthcare professionals involved in breast cancer care, offering the latest updates and expert insights across key subtypes of early breast cancer.
These guidelines emphasize the critical role of low-dose CT screening in high-risk populations for early detection, provide a comprehensive overview of best practices for diagnosis
ESMO TAT Asia Congress, will be held from 18-20 July 2025 Hong Kong SAR, China
ESMO Asia Congress 2025, will be held from 5 to 7 December in Singapore
This document comprises a surgical consensus of evidence-based guidelines to provide local recommendations on contemporary real-world best practices for screening, diagnosis, staging, multimodal management (including neoadjuvant, perioperative ‘sandwich’ and adjuvant therapy regimens), operative procedures and post-resection surveillance for early-stage resectable (stages 1A-IIIB-N2) non-small cell lung cancer (NSCLC).
We know it can be difficult to talk about cancer. That’s why we’re organising two workshops in January to help you tell your story through writing or artwork.
5th International Congress of the Asian Oncology Society (AOS 2025) to be held at COEX, Seoul, Korea on July 3-4, 2025
We are pleased to inform that the position paper has been updated and finalised to incorporate the names of endorsing societies on the second page.
ESMO has planned the Educational Courses for participants in the Asian-Pacific region.
The female representation at Japanese Society of Medical Oncology pre congress workshop in Fukuoka Japan.
